These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 5642106)
41. Effect of dextran on platelet activation by polymerizing fibrin. Ts'ao CH; Krajewski DV Am J Pathol; 1982 Jan; 106(1):1-7. PubMed ID: 6172983 [TBL] [Abstract][Full Text] [Related]
42. Protein changes in activated human platelets. Giometti CS; Anderson NG Clin Chem; 1984 Dec; 30(12 Pt 1):2078-83. PubMed ID: 6437697 [TBL] [Abstract][Full Text] [Related]
43. Effects of plasma expanders on coagulation and hemostasis: dextran hydroxyethyl starch, and other macromolecules revisited. Alexander B Prog Clin Biol Res; 1978; 19():293-330. PubMed ID: 78500 [No Abstract] [Full Text] [Related]
44. Effect of inhibitors of arachidonic acid conversion in platelets on thrombin-fibrinogen interaction and thrombin tolerance. Shapovalova EM; Rudzevich AJ Bull Exp Biol Med; 2007 Oct; 144(4):527-8. PubMed ID: 18642704 [TBL] [Abstract][Full Text] [Related]
45. Preparation of succinylthrombin and its effects in vivo on the coagulation system. Nakagomi K; Yokota I; Ajisaka K Thromb Res; 1991 Jul; 63(1):111-21. PubMed ID: 1948815 [TBL] [Abstract][Full Text] [Related]
46. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain. Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293 [TBL] [Abstract][Full Text] [Related]
47. [Metabolism of I131-fibrinogen following intravenous and intraperitoneal administration after thrombin loading and blood loss]. Tsushko VS Vopr Med Khim; 1980; 26(2):227-32. PubMed ID: 7456352 [TBL] [Abstract][Full Text] [Related]
48. Unstimulated and thrombin-stimulated platelets binding to immobilized fibrinogen and fibrin on polystyrene supports. Martínez-Sales V; Vila V; Réganon E; Aznar J Haemostasis; 1995; 25(4):158-65. PubMed ID: 7557654 [TBL] [Abstract][Full Text] [Related]
49. Comparative effects o ADP and thrombin in producing stasis thrombosis. Stuart RK; Thomas DP Thromb Diath Haemorrh; 1967 Dec; 18(3-4):537-43. PubMed ID: 5590242 [No Abstract] [Full Text] [Related]
50. Increased platelet, but unaltered fibrinogen, accumulation in experimental thrombi in alloxan-induced diabetic rabbits. Winocour PD; Hatton MW; Richardson M Exp Mol Pathol; 1992 Oct; 57(2):134-44. PubMed ID: 1426157 [TBL] [Abstract][Full Text] [Related]
51. The molecular-mass dependence of dextran sulfate enhancement of inactivation of thrombin and fibrinogen and on factor Xa neutralization by antithrombin III. Oshima G Biol Chem Hoppe Seyler; 1989 Jul; 370(7):715-21. PubMed ID: 2476159 [TBL] [Abstract][Full Text] [Related]
52. Effect of low molecular weight dextran on acrocyanosis and scleroderma. Zackheim HS; Farber EM; Aschheim E Dermatologica; 1969; 139(2):145-53. PubMed ID: 5810899 [No Abstract] [Full Text] [Related]
53. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin. Peerschke EI Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566 [TBL] [Abstract][Full Text] [Related]